A report on the the 12th Regional Teaching Course in sub-Saharan Africa, held virtually and hosted at Makerere University, Kampala, Uganda, on 10-11 September 2021.
EAN Congress 2025 relocated to HELSINKI due to UN summit (dates remain 21-24 June)
September 20, 2024
Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.
EAN co-hosting G7 side-event in Ancona, Italy, on 8 October
September 13, 2024
Upcoming Joint Sessions at Partner Societies’ Congresses
August 26, 2024
Latest Posts
-
-
Breaking newsCOVID-19
Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series
November 3, 2021In this single-center prospective case study the authors report patients with neurological autoimmunity in temporal association (≤6 weeks) with SARS-CoV-2 vaccinations and without other triggers. -
Breaking newsCOVID-19
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
November 3, 2021In this article the authors examined the characteristics of COVID-19 severity in an international sample of people with MS. -
Breaking newsCOVID-19
EEG Abnormalities and Their Radiographic Correlates in a COVID-19 Inpatient Cohort
November 3, 2021The objective of this study was to identify the prevalence of EEG abnormalities in patients with COVID-19 with neurologic changes, their associated neuroimaging abnormalities and rates of mortality. -
Breaking newsCOVID-19
Autoimmune Encephalitis Post-SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes
November 3, 2021In this article the authors aimed to determine the frequency and diagnostic features of COVID-19 related AE. -
Breaking newsCOVID-19
Immune signatures underlying post-acute COVID-19 lung sequelae
November 3, 2021In this article the authors performed high-dimensional characterization of the pathophysiological and immune traits of aged COVID-19 convalescents, and correlated the local and systemic immune profiles with pulmonary function and lung imaging. -
Breaking newsCOVID-19
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
November 3, 2021In this article the authors longitudinally profiled vaccine responses in SARS-CoV-2 naïve and recovered individuals for 6 months after vaccination. -
Breaking newsCOVID-19
Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death case
November 3, 2021A systematic review of 735 SARS-CoV-2-associated deaths using conventional autopsy, ultrasound-guided autopsy, postmortem CT and medical records. -
This Review provides the structural and cellular foundations for understanding the multistep SARS-CoV-2 entry process.
-
Breaking newsCOVID-19
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
November 3, 2021In this article the authors analysed the development of anti-SARS-CoV-2 antibody and T cell responses in previously infected (recovered) or uninfected (naive) individuals that received mRNA vaccines to SARS-CoV-2. -
Breaking newsCOVID-19
A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries
November 3, 2021The aim of this study was to estimate weather-dependent signatures in the early phase of the pandemic, while controlling for socio-economic factors and non-pharmaceutical interventions. -
Breaking newsCOVID-19
COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients
November 3, 2021The authors of this study aimed to characterise myofiber structure in the diaphragm of critically ill patients with COVID-19. -
Breaking newsCOVID-19
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial
November 3, 2021The objective of this study was to determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19. -
Breaking newsCOVID-19
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
November 3, 2021Evaluation of the effects of therapeutic-dose low-molecular-weight heparin vs institutional standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19. -
Breaking newsCOVID-19
Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021
November 3, 2021The objective of this study was to assess reports of GBS received in the Vaccine Adverse Event Reporting System (VAERS) following Ad26.COV2.S vaccination.